InflammationA process of the immune system that involves chemicals released by immune cells (i.e. white blood cells) inducing localized heat, swelling, redness, and pain to an area that occurs when tissue becomes damaged or infected from a pathogen, and usually results in the desctruction and removal of the pathogen and/or healing to the tissue. In the case of myelin oligodendrocyte glycoprotein antibody disease (MOGAD), inflammation is the result of the incorrect targeting of the myelin oligodendrocyte glycoprotein (MOG) by the immune system, resulting in damage to myelin sheaths. of the active tissues of the brain caused by an autoimmuneA disease in which the immune system incorrectly targets and attacks an individual's own healthy cells. response due to the presence of the MOGA type of protein involved in cell adhesion. Present throughout myelin sheaths. AntibodyA protective protein produced by your immune system that attaches to antigens (foreign substances), such as bacteria and toxins, and removes them from your body. In myelin oligodendrocyte glycoproten antibody disease (MOGAD), the body incorrectly produces an antibody that targets myelin oligodendrocyte glycoprotein, a component of the myelin sheath in the central nervous system..
MOG-EM
Related Posts
Eight Years Old and Running for Her Brother
When Aria laced up her trainers for the AJ Bell Great Manchester Run, she wasn’t just racing — she was advocating for her twin brother
Global Leaders in MOGAD Research Convened May 14-16, 2026
Leading international clinicians, researchers, advocates, and industry collaborators gathered in Cambridge, Massachusetts, for two major back-to-back MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease meetings focused onInflammation of the optic nerve that may be classified as unilateral (affecting one eye) or bilateral (affecting both eyes) that may result in vision changes, vision loss, and/or pain with eye movement. research priorities, clinical trials, therapeutic
The State of MOGAD Science: Research, Treatments & What’s Next
The State of MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Science: What We Learned Together This MOGADOften referred to as MOGAD, Anti-MOG, MOG Ab+, MOG Antibody Disease, MOG Associated Antibody Disease, MOG positive disease Awareness Month, we came together with the Siegel Rare NeuroimmuneA term that refers to the components of the immune system that acts in and affects the central nervous system. Association (SRNA) to host
